CML development was significantly slower in mice receiving BM cells transduced with BCR-ABL- TXNIP-GFP than in those receiving BM cells transduced with BCR-ABL-GFP (Fig. 4B). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.